PAS
GILD icon

Park Avenue Securities’s Gilead Sciences GILD Stock Holding History

Park Avenue Securities’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9M Sell
71,241
-9,174
-11% -$1.21M 0.06% 256
2026
Q1 		$11.2M Sell
80,415
-564
-0.7% -$79K 0.09% 177
2025
Q4 		$9.94M Buy
80,979
+2,163
+3% +$263K 0.08% 187
2025
Q3 		$8.75M Buy
78,816
+4,088
+5% +$465K 0.07% 215
2025
Q2 		$8.29M Buy
74,728
+34,195
+84% +$3.64M 0.08% 189
2025
Q1 		$4.54M Buy
40,533
+11,780
+41% +$1.22M 0.06% 217
2024
Q4 		$2.66M Buy
28,753
+6,878
+31% +$619K 0.03% 385
2024
Q3 		$1.83M Sell
21,875
-6,133
-22% -$468K 0.02% 455
2024
Q2 		$1.92M Sell
28,008
-7,433
-21% -$496K 0.02% 429
2024
Q1 		$2.6M Sell
35,441
-28,964
-45% -$2.23M 0.03% 329
2023
Q4 		$5.22M Buy
64,405
+8,079
+14% +$629K 0.07% 177
2023
Q3 		$4.22M Buy
56,326
+5,436
+11% +$418K 0.07% 178
2023
Q2 		$3.92M Buy
50,890
+2,684
+6% +$214K 0.06% 201
2023
Q1 		$4M Sell
48,206
-2,934
-6% -$243K 0.07% 177
2022
Q4 		$4.39M Buy
51,140
+12,303
+32% +$974K 0.08% 164
2022
Q3 		$2.4M Buy
38,837
+8,221
+27% +$518K 0.05% 225
2022
Q2 		$1.89M Buy
30,616
+14,694
+92% +$910K 0.04% 281
2022
Q1 		$947K Buy
15,922
+2,212
+16% +$141K 0.02% 504
2021
Q4 		$995K Buy
13,710
+1,438
+12% +$99K 0.02% 480
2021
Q3 		$857K Buy
12,272
+323
+3% +$22.7K 0.02% 476
2021
Q2 		$823K Buy
11,949
+1,001
+9% +$66.8K 0.02% 479
2021
Q1 		$708K Buy
10,948
+2,130
+24% +$137K 0.02% 475
2020
Q4 		$514K Sell
8,818
-55
-0.6% -$3.32K 0.01% 492
2020
Q3 		$561K Sell
8,873
-201
-2% -$13.9K 0.02% 406
2020
Q2 		$698K Buy
+9,074
New +$695K 0.03% 264
2020
Q1 		– Sell
-9,703
Closed -$631K – 402
2019
Q4 		$631K Buy
9,703
+380
+4% +$24.7K 0.03% 250
2019
Q3 		$591K Buy
+9,323
New +$609K 0.03% 223
2019
Q2 		– Sell
-3,222
Closed -$212K – 325
2019
Q1 		$212K Buy
+3,222
New +$214K 0.01% 429
2016
Q2 		– Sell
-2,418
Closed -$228K – 98
2016
Q1 		$228K Buy
+2,418
New +$218K 0.04% 71

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Park Avenue Securities's GILD Position: Q2 2026 in Review

Park Avenue Securities reduced its Gilead Sciences (GILD) stake by 11% in Q2 2026, selling an estimated $1.21M and leaving 71,241 shares worth $9M. The position accounts for 0.06% of the portfolio, ranked #256.

Park Avenue Securities first reported a position in GILD in Q1 2016 and has held it in 29 quarters since. The position peaked at $11.2M in Q1 2026. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Park Avenue Securities held 71,241 shares of Gilead Sciences worth $9M as of Q2 2026.
  • Park Avenue Securities sold 9,174 Gilead Sciences shares in Q2 2026, an estimated $1.21M.
  • Gilead Sciences made up 0.06% of Park Avenue Securities's portfolio in Q2 2026, its #256 holding.
  • Park Avenue Securities first reported a position in Gilead Sciences in Q1 2016 and has held it in 29 quarters since.
  • Park Avenue Securities's Gilead Sciences position peaked at $11.2M in Q1 2026.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Park Avenue Securities's 13F filing for Q2 2026, filed 20 Jul 2026.